Fernanda Marincek

Fernanda Marincek

Auto-generated profile, based on publicly available information

Fernanda Marincek

Infection, Immunity and Global Health Parkville Victoria Murdoch Children's Research Institute

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2026 in The Lancet Regional Health - Western Pacific
Verified
Journal Article
Open access
FMFernanda Marincek
Fernanda Marincek
BTBeth Temple
Beth Temple
SMSam Manna
Sam Manna
HTHau Phuc Tran
Hau Phuc Tran
VDVo Thi Trang Dai
Vo Thi Trang Dai
CSCatherine Satzke
Catherine Satzke
Streptococcus pneumoniae (the pneumococcus) is one of the main causes of childhood mortality. Understanding pneumococcal serotype and lineage distribution in children is important for vaccine decision-making. We undertook a secondary analysis of nasopharyngeal swabs collected from unvaccinated children as part of pneumococcal vaccine studies to provide a comprehensive picture of pneumococcal carriage epidemiology in Vietnamese children during the first 60 months of life. We analysed 4375 nasopharyngeal swabs from unvaccinated children to assess overall and vaccine-type pneumococcal carriage at 6, 12, 18, 24, and 60 months of age. For the latter three age groups, serotype distribution and genetic lineages (Global Pneumococcal Sequence Cluster, GPSCs) were described overall and by age. We also evaluated the prevalence of antimicrobial resistance (AMR) genes and multi-drug resistance (MDR), comparing vaccine-type and non-vaccine-type pneumococci. Overall pneumococcal carriage was 21·7% (952/4375) with a total of 27 serotypes detected. Serotype coverage was similar across products Pneumosil (68·6% [95% CI 65·5–71·7%], 595/867), Prevenar13 (70·0% [95% CI 67·0–73·1%], 607/867), and Vaxneuvance (70·0% [95% CI 67·0–73·1%], 607/867), and lower for Synflorix (41·5% [95% CI 38·2–44·8%], 360/867) p < 0·05 vs Pneumosil, Prevenar13 or Vaxneuvance. In total, 2444 swabs were tested at 18, 24, and 60 months. Thirty distinct GPSCs were identified, with their distribution remaining stable across these ages. AMR genes were highly prevalent, detected in 98·9% (360/364) of samples. Synflorix provided lower serotype coverage than other PCVs, largely driven by the prevalence of serotype 6A, which is not included in Synflorix formulation. Serotype, lineage distribution, and prevalence of AMR genes across the sampled age groups remained consistent, indicating that these distributions are broadly representative of young unvaccinated children, helping to guide optimal approaches for pneumococcal surveillance in low- and middle-income countries. 10.13039/501100000925 National Health and Medical Research Council , 10.13039/100000865 Bill & Melinda Gates Foundation , 10.13039/100014555 Murdoch Children's Research Institute .

5 September 2025 in VeriXiv
Verified
Preprint
Open access
FMFernanda Marincek
Fernanda Marincek
BTBeth Temple
Beth Temple
SMSam Manna
Sam Manna
HTHau Phuc Tran
Hau Phuc Tran
VDVo Thi Trang Dai
Vo Thi Trang Dai
CSCatherine Satzke
Catherine Satzke